IRulya Therapeutics
IRLANasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Market cap
$436.586 M
$40.27 +16.89%
Close of 21 Oct 2026
As of 21 Oct 2026, IRulya Therapeutics (IRLA) has a market capitalization of $436.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
-$84.0M
Loss-making
Shares outstanding
1,017,063
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
IRulya Therapeutics lists more than one class of stock. Company figures above cover all classes combined.
Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap
All 162 →- #66Eikon TherapeuticsEIKN$443.1M
- #67Autolus TherapeuticsAUTL$441.8M
- #68IRulya TherapeuticsIRLA$436.6M
- #69ProkidneyPROK$435.3M
- #70AgomAb TherapeuticsAGMB$429.9M
What if IRulya Therapeutics were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for IRulya Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Oct 2026. Read the methodology.